Gait Characteristics at Different Speeds in Individuals With Stroke
Spatiotemporal Characteristics of Gait at Different Walking Speeds in Individuals With Stroke
1 other identifier
observational
15
1 country
1
Brief Summary
Stroke is the second leading cause of death and the third leading cause of death combined with disability worldwide. Despite improved recognition and management of stroke risk factors, the risk of stroke has increased by 50% in the last two decades due to increased life expectancy, currently affecting one in every four individuals. If this trend continues, by 2030, it is estimated that 12 million people will die from stroke, and 70 million will live with its consequences. Stroke leads to significant changes in the spatiotemporal parameters of gait. Spatial parameters include step length, stride length, and step width, while temporal parameters comprise cadence, stance phase, double support phase (DSP), and swing phase. Gait speed, incorporating both spatial and temporal elements, is classified as a spatiotemporal parameter. Compared to healthy individuals, people post-stroke tend to have increased DSP and stance phases, shortened step lengths, and widened step widths. Asymmetries between the paretic and non-paretic limbs further disrupt gait symmetry. Previous studies have shown that during prolonged walking tasks such as the 6-minute walk test, both gait speed and symmetry deteriorate in the later stages, potentially due to fatigue. However, changes in walking speed itself may also influence gait symmetry. From this perspective, the aim of this study is to investigate how spatiotemporal gait parameters vary across different walking speeds in individuals with stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 3, 2025
CompletedFirst Posted
Study publicly available on registry
August 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2026
CompletedMarch 12, 2026
March 1, 2026
7 months
August 3, 2025
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Stance Phase
Stance phase of hemiplegic side during walking. This outcome will be obtained as a result of the gait analysis
Baseline
Hemiplegic Side Step Length
Step legth of hemiplegic side during walking. This outcome will be obtained as a result of the gait analysis
Baseline
Double Support Phase
Double support phase during walking. This outcome will be obtained as a result of the gait analysis
Baseline
Secondary Outcomes (1)
Stride Length
Baseline
Other Outcomes (3)
Fugl Meyer Lower Extremity
Baseline
Berg Balance Scale
Baseline
Functional Ambulation Category
Baseline
Study Arms (3)
Self Selected Speed
Participants in this group will perform the gait analysis at their preferred comfortable walking speed.
Slow Walking Speed
Participants in this group will walk at a speed approximately 25% slower than their comfortable walking speed.
Fast Walking Speed
Participants in this group will walk at a speed approximately 25% faster than their comfortable walking speed.
Interventions
All participants will undergo gait analysis at three different walking speeds.
Eligibility Criteria
Stroke survivors.
You may qualify if:
- Having an ICD-10 diagnosis code of G.81 Hemiplegia
- Ability to walk with or without assistance (Functional Ambulation Classification score of 2 or higher)
You may not qualify if:
- Presence of any known additional neurological or orthopedic condition that may affect walking
- Inability to complete the tests due to cognitive and/or physical reasons
- Inability to complete the analysis at walking speeds increased or decreased by 25%
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital
Ankara, None Selected, 06800, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 3, 2025
First Posted
August 11, 2025
Study Start
August 1, 2025
Primary Completion
February 27, 2026
Study Completion
March 10, 2026
Last Updated
March 12, 2026
Record last verified: 2026-03